Abacus Global Management, Inc. (ABX) Earnings Call Transcript & Summary

August 7, 2025

New York Stock Exchange US Financials Insurance earnings 44 min

Earnings Call Speaker Segments

Robert Phillips

executive
#1

Thanks, operator, and I appreciate all of you being on Abacus Global Management's Second Quarter 2025 Earnings Call. Joining me are Jay Jackson, our Chairman and Chief Executive Officer; Elena Plesco, our Chief Capital Officer; and Bill McCauley, our Chief Financial Officer. At 4:15 p.m. Eastern Time today, Abacus Global Management put out its second quarter 2025 results, and on this afternoon's call, participants can pose questions regarding those results. Before we get started, Abacus Global Management directs participants on this call to the Investor web page, ir.abacusgm.com, where the press release, investor information and SEC filings discussing risks that may impact the business can be found. Abacus Global Management particularly points participants to the presentation furnished today on Form 8-K with the Securities and Exchange Commission, and wants to remind listeners that certain comments made today might include forward-looking statements and therefore will carry risks and uncertainties that, should they occur, could materially affect results. For additional details on the risks, uncertainties and assumptions tied to forward-looking statements, please consult Abacus Global Management's public filings. Throughout the call, we will mention certain non-GAAP financial measures. While we believe these measures offer useful supplemental information regarding our financial performance, they are not recognized measures and lack standardized meanings under U.S. generally accepted accounting principles or GAAP. Please review our public filings for further information about our non-GAAP financial measures, including references to comparable GAAP measures. With that, I'd now like to turn the call over to Jay Jackson, Chief Executive Officer.

Jay Jackson

executive
#2

Thanks, Rob, and I appreciate all of you taking the time to join us today and for your interest in Abacus Global Management. It's great to have you with us for our second quarter 2025 earnings call. Once Elena, Bill, and I finish up with our prepared remarks, we'll turn things over to you for questions. We just wrapped up yet another outstanding quarter of record profitable growth, and at the same time we kept pushing forward on our strategic initiatives aimed at establishing Abacus as a top-tier alternative asset and wealth management platform. During the second quarter of 2025, our total revenue nearly doubled compared to the same period last year, reaching $56.2 million, and we also grew adjusted net income to $21.9 million along with adjusted EBITDA of $31.5 million. This strong showing came from robust appetite for less correlated investments and policyholder liquidity solutions, which widens our competitive moat and fuels our future growth. Our asset management offerings keep building momentum, with new AUM inflows of roughly $142 million. On top of that, our ETFs saw strong momentum in asset flows, pushing total gross AUM to almost $3.3 billion. Thanks to our solid execution in the first half, powered by our resilient business model, we've been able to raise our full year 2025 outlook. We now anticipate adjusted net income in the range of $74 million to $80 million, which represents strong year-over-year growth of 59% to 72%. Bill will walk you through our second quarter financial performance in more detail in just a bit. As we keep evolving and scaling, I want to take a moment to give everyone a refresher on how our business model and revenue generation work, especially when you compare us to other major players in the private credit space. Fundamentally, we're an originator and market maker that controls its own destiny by leading price discovery that's driven by genuine market demand. Much like the biggest private credit companies, we originate high-quality assets and then sell a portion of those assets at prevailing market prices, which are determined by actual investor demand. Our own managed funds benefit from our originations, and each one operates with distinct investment policies and independent investment objectives tailored to their specific investor base; we then syndicate the remaining assets to institutional third-party investors at those same market-driven prices. This dual approach lets us maximize the value of our origination capabilities while serving diverse investor needs with pricing that reflects current market dynamics. Our investors come to Abacus specifically to tap into our investment management expertise and proprietary investment products. Most importantly, what they want is to invest in assets originated by Abacus, not assets originated by other companies. This direct link between our origination capabilities and investor demand is fundamental to our value proposition and competitive advantage. Our origination platform is a valuable and unique proposition that sets us apart from other industry players; this platform ensures we stay in control while offering access to a unique asset class that's seeing high demand from investors seeking private credit instruments. Looking at the broader market, while the near-term macro environment remains dynamic, Abacus' unique business model and operational acumen ensure we remain strongly positioned to navigate current conditions. To be more specific, our origination volumes keep growing as policyholders look for more ways to access liquidity, and at the same time, demand for our assets has risen as institutional asset managers and investors chase opportunities for yield that are less correlated. This durable model — serving both consumers who want liquidity and investors who want yield — creates strategic advantages no matter where we are in a market cycle, and it's backed by our solid financial foundation, which includes $74.8 million in cash and cash equivalents and $387.3 million in balance sheet policy assets as of June 30, 2025. Over in our Life Solutions business, we recorded a realized gain of $58.3 million for the quarter, which shows how strong investor demand is and confirms our market-making approach works. These realized gains show the premium market participants assign to the assets we originate, confirming that our mark-to-market approach to value comes from real-time market dynamics. That highlights how effective our origination-focused strategy is and our capacity to capture genuine market value. So that investors get more transparency into our business model and how we execute strategically, we're rolling out additional key performance indicators that Elena Plesco, our Chief Capital Officer, will walk through in her remarks; these metrics will give you a deeper look at how we're carrying out our overall business initiatives and, in particular, at how we manage our balance sheet. Alongside our strong second quarter results, we grew our brand recognition, which included launching a new corporate-focused commercial campaign on June 12, 2025, at our Investor Day & Longevity Summit held at NASDAQ in New York City. The event focused on Abacus' positioning as a visionary leader in longevity-based asset management. The feedback we keep getting on our new branding is still encouraging. As prudent stewards of capital, in early June our Board of Directors authorized a new $20 million share repurchase program effective June 5, 2025, running for up to 18 months. Also, in late July, we finished an exchange offer and consent solicitation tied to our outstanding warrants as we keep simplifying our capital structure; we managed to tender 88% of the warrants at 0.23 per warrant, with the remaining 12% to be converted at 0.207 shares per warrant on August 14. Going forward, we're building on our excellent first half achievements and growing brand recognition, which is driving more policy originations, more interest in our asset management offerings and our expansion into wealth management, all of which led us to raise our full year adjusted net income target. We stay committed to our mission of establishing Abacus as the go-to player in alternative assets and wealth management. Our distinct market approach, combined with access to noncorrelated assets, creates a powerful competitive advantage; this foundation lets us not only to weather market uncertainty, but to capitalize on it and build an even more resilient business; with that, I'll now hand it over to our Chief Capital Officer, Elena Plesco, who joined the Abacus team a little over a year ago from KKR, where she served as Co-Head of Specialty Finance. Elena is going to walk through some extra KPIs, which will give you deeper insight and more transparency when it comes to how our business is performing.

Elena Plesco

executive
#3

Thanks, Jay. As Jay pointed out, I want to walk through a few of the KPIs we already track and some new ones, since we think they matter for grasping how efficiently our balance sheet works and how we put capital to work. To start, we keep a very close eye on the metrics around portfolio turnover and velocity. Within financial services, the turnover ratio serves as a basic instrument for gauging balance sheet velocity and capital efficiency — more precisely, the speed at which invested capital and realized returns are cycled. For Q2 2025, the annualized turnover ratio came in at 2.3x. Because demand strengthened after Liberation Day, that ratio sits a bit above the long-term average target of 1.5 to 2x we had previously stated. Across Q2, we bought 250 new policies and sold 399 policies, which works out to a sale to purchase ratio of 1.6x — a sign of faster velocity. That stacks up well against the quarter before, when a 0.69x sales to purchase ratio came with 171 purchases and 118 sales during the quarter. It shows how our selective selling activity picked up after a stretch of aggregation on the balance sheet. Next, we also kept our attention on strategic portfolio aging and inventory management. One crucial measure of how well we manage the balance sheet is whether we can monetize seasoned policies at the best moment; in the second quarter of 2025, policies we sold had been held an average of 243 days, versus 229 days for owned positions, which underscores how efficiently we rotate mature inventory while keeping overall portfolio quality intact. That 14-day delta for sold policies, though narrower than the exceptional 82-day delta of the first quarter of 2025 — 294 versus 212 days — still confirms our proactive approach of taking gains on well-seasoned positions instead of selling reactively. This figure shows how well we can get out of policies we've held for a while, and it makes clear that we're handling the balance sheet with a plan instead of just churning through whatever we bought most recently. Third, our health portfolio tells you a lot about where our strongest thinking lies. You can see how dedicated we are to keeping the positions we believe in most: policies we've owned for more than 365 days make up roughly 15% of the value of our whole portfolio, cash included. Those long-held positions carry a weighted average grade that reflects their low risk, a weighted average life expectancy of 50 months, and a weighted average age of 85 years, which speaks to how solid our decisions to hold for the long term have been. That heavy weighting toward our highest-conviction picks shows how strictly we build the portfolio and how much faith we place in our ability to underwrite. Last, we keep a close watch on how our unit economics are performing. The unit economics at the policy level confirm that our active management approach and operational rigor are working. Realized gain on sale is the gap between the amount Abacus pays to originate a policy and the price actually received when that policy is sold to investors, who rely on their own valuation data to judge what the assets are worth in the market. For Q2 2025, our average realized gain on sale comes to 26.3%, and that figure appears in our audited financial statements. For the past 1.5 years, this figure has held steady above 20%, showing what we can do when it comes to producing reliable returns by managing our balance sheet strategically, all while keeping tight control over costs across our operations. We'll keep sharing updates on these extra and historical KPIs as the quarters come; so with that, I'll pass things to our CFO, Bill McCauley, who will walk through the details of what we delivered in the second quarter.

Bill McCauley

executive
#4

Thanks, Elena, and good morning, everyone. Like Jay said, we delivered yet another outstanding quarter when it comes to growing the top line and generating profit. Revenue for Q2 2025 rose 93%, reaching $56.2 million, up from $29.1 million during the same period last year. The main thing pushing our revenue higher was stronger Life Solutions — what we used to call active management and origination revenues — along with meaningful contributions from asset management fees. What keeps driving Life Solutions results is our extremely efficient origination platform together with our trading division. Capital deployed rose 16%, hitting $121.8 million in Q2 2025 versus $104.7 million a year earlier; beyond deploying capital, we also enjoyed a very strong quarter when it came to monetizing originations. During Q2 2025, Abacus syndicated 399 policies across 15 separate counterparties, amounting to $208.4 million in fair value and $58.3 million in total realized gains. Given the expansion in policy origination and capital deployment, as of June 30, 2025, Abacus carries 600 policies worth $387.3 million on its balance sheet. We're quite enthusiastic about what the Asset Management business is contributing, since this marks the second complete quarter of asset management fees stemming from the acquisitions that wrapped up late in 2024. Q2 2025 brought $8.8 million in revenue for that business segment. Now onto expenses. Total operating expenses — leaving out unrealized and realized gains and losses on investments plus the change in fair value of debt — came to roughly $27.4 million for Q2 2025, versus $20.1 million a year earlier. The year-over-year rise was mostly due to higher depreciation and amortization, bringing in operating expenses from the companies acquired during Q4 2024, and more marketing spending to support our growth profile. Usually, the company sees the payoff from marketing spend within 90 to 120 days. On an adjusted basis — stripping out noncash stock compensation, business acquisition costs, amortization and the change in fair value of warrant liability — net income for Q2 2025 climbed 87% to $21.9 million, compared with $11.7 million a year earlier. Adjusted EBITDA for the quarter reached $31.5 million, up from $16.7 million a year earlier, an 89% increase. Adjusted EBITDA margin came in at 56.1% for the quarter, versus 57.5% a year earlier. GAAP net income attributable to stockholders for the quarter was $17.6 million, compared with $0.7 million a year earlier, mainly because of higher revenues and the gain on the change in fair value of warrant liability, partly offset by higher operating costs from our acquisitions. Now let's look at our balance sheet metrics; for Q2 2025, adjusted return on equity was 21% and adjusted return on invested capital was 22%, both showing how highly profitable our business model is. As of June 30, 2025, the company held cash and cash equivalents of $74.8 million, balance sheet policy assets of $387.3 million and outstanding long-term debt of $357 million. Like Jay said earlier, because of how well we did in the first half and how confident we feel about the momentum in our business, we're lifting our outlook for the entire 2025 year on adjusted net income, moving it to a range of $74 million to $80 million, which is higher than the $70 million to $78 million we had before. That updated range represents growth of 59% to 72% when measured against adjusted net income of $46.5 million for all of 2024; to put it simply, we're happy to keep up our streak of setting records for revenue while also growing profitability by a substantial amount. At this point I'll hand things back to Jay Jackson, our CEO, to make some closing remarks.

Jay Jackson

executive
#5

Thank you, Bill. Prior to taking questions, we thought it would be helpful to address and clarify 2 particular topics that come up fairly often. First, how we account for revenue on policy sales. People have asked us how revenue is measured or tracked when policies are sold. Under Abacus' vertically integrated approach, value gets generated at several stages, such as policy origination, policy servicing and the policy sale, instead of only recognizing value from policy maturities or valuing the portfolio using forecasted discount rates and life expectancy estimates. Realized gain on sale reflects the immediate economic value produced once a policy transaction closes, and it lets investors see how effectively we turn most of our assets into cash inside a 12-month window. Since this metric shows the true market value our origination platform generates, it offers a transparent view of our operational results. Rather than relying on theoretical valuations, realized gain on sale shows the actual premium investors are prepared to pay for assets we originate in live market transactions; we monitor gain on sale historically, which shapes our expectations for where newly originated assets might trade and, consequently, how they get marked to mirror the latest economic conditions. On average, our realizations have met or surpassed the marks at which assets are carried on our balance sheet. Additionally, alongside the average realized gain on sale, you can now follow several other velocity-based KPIs that Elena mentioned previously, giving you thorough visibility into our performance and the market's validation of our strategy. Second, Abacus managed funds compared with third-party syndication. We're asked what share of policies gets sold off our balance sheet into Abacus managed funds versus being syndicated to outside parties. As noted earlier, this two-pronged approach mirrors what any other top private credit asset manager does. To be specific, we create high-quality assets and then dispose of a portion of them at prevailing market prices set by genuine investor demand. Some are originated for funds Abacus manages, while the remainder goes to other institutional third parties at those same market-driven prices; this direct link among our origination, market-making capabilities and investor demand sits at the heart of our value proposition and competitive edge. Investors turn to Abacus precisely to gain access to our proprietary originations, policy servicing and valuation expertise along with our investment products. How much we originate for related party funds may shift from quarter to quarter depending on capital availability and other investor demand. Related party transactions for the year to date appear quarterly in the 10-Q under the related party transaction section. We trust this brings added clarity to our business. To wrap up, our record second quarter and first half results keep affirming our resilient and differentiated business model. We're strategically positioned to prosper despite today's market uncertainties, owing to our distinctive value proposition that appeals to both policyholders and investors seeking noncorrelated assets. A significant opportunity lies in front of us in the market, and we feel energized about drawing on our record of 20 years of steady financial results to fuel expansion that is sustainable and profitable across the long term. Once more, thank you everyone for being with us today, and we're grateful for your interest in Abacus Global Management. Having said that, we're ready to take your questions.

Patrick Davitt

analyst
#6

I appreciate the commentary you provided at the close regarding how you approach sourcing policies for your in-house funds as opposed to outside parties. That logic tracks; however, considering all that transpired during the prior quarter, some skepticism may persist. So, to begin, might you offer additional detail on the breakdown of sales across the second and third quarters? And on a wider level, how can those of us who remain doubtful become more assured that these funds are genuinely acquiring policies at the market bid price that your outside parties pay? Put differently, which compliance barriers and/or selection procedures for securities exist to guarantee the absence of any conflict of interest?

Jay Jackson

executive
#7

Certainly. Thanks, Patrick. I'll address the latter portion of your inquiry first. In a certain respect, those funds operate independently. What I mean is that every one of them possesses — each holds its own policy document, its own asset management, plus its own goals, investment goals tied to the duration and time frame of those funds; furthermore, every fund must obtain a third-party actuarial market valuation of the underlying assets it buys, once more, every quarter for its own NAV; Abacus has no authority over that whatsoever; and beyond that, it likewise confirms where those policies are priced and where those policies are priced specifically for that fund's objective; so on top of that, once again, we engage a third party — we bring in a third-party valuation firm each quarter to appraise the assets of those underlying funds. Thus, to assist in validating and providing extra reassurance to anyone worried about where the pricing stands on those policies, that is another item we have a third party examine for every single fund. The remaining portion of that question is, well, what were the precise percentages? If we dissect that, and you'll see this in the forthcoming Q, as a share of total revenue in Q2, what we'd term related party transactions made up 29% of total revenue in Q2; and for the year to date, that would amount to 17%; and that would encompass the Carlisle Funds in Luxembourg along with all longevity funds we hold. So specifically, Q2, that would be 29% of total revenue and merely 17% overall for the year; so I trust that gives you a bit more clarity on the matter.

Patrick Davitt

analyst
#8

Yes, that helps. As a fast follow-up, it appears roughly 5 million shares were bought back, yet the average share count hardly moved. So I suppose that happened quite late in the quarter. So first, is my read correct? And then projecting ahead, I suppose that would imply you've essentially completely offset the warrant exchange as we model into 3Q?

Jay Jackson

executive
#9

Yes, that's right, Patrick. When we examined how the stock was priced, we approached it the same way you did. And when we also factored in the warrant exchange, it — with the repurchase program we had running, including purchases by insiders, we felt quite confident that the extra dilution you could see from the warrant conversion was canceled out by all that repurchasing — by the buyback that occurred. Nearly — in fact, our buyback involved a greater number of shares than the warrant exchange. So you could — I mean, one might claim it was net accretive, but I won't put forward that claim at this point.

Crispin Love

analyst
#10

Jay, you mentioned $58 million of realized gains for the quarter. Could you tell us what the unrealized gains were during that same period? And regarding that $58 million realized, my assumption is those mostly came from converting unrealized amounts over the previous couple of quarters. So if you could just give us the net gain loss, if that's clear.

Jay Jackson

executive
#11

Sure. Bill will take the second part. But about the $58 million, you've got it exactly right; we were realizing — a large share of that came through unrealized gains from the quarter before, which I think, once again, says a lot about where our valuation had placed those policies. Because keep in mind, something Elena pointed out during her remarks was that during Q2, the average trade spread we recognized was 26%, above our historical average of 22%. And that, I believe, says a great deal about demand for the policies and the underlying assets we held. Bill will cover the unrealized portion.

Bill McCauley

executive
#12

Yes. The unrealized gain for the quarter was about $17 million.

Crispin Love

analyst
#13

Great, that helps. Now regarding the outlook, you raised it, but putting it very simply, annualizing the first half into the second half gives you $78 million, just as an illustration. Could you talk about what you expect for the back half in terms of earnings? Should we anticipate growth versus the first half? Or are there particular pluses and minuses to flag when comparing the two halves on an earnings basis?

Jay Jackson

executive
#14

Certainly. Growth is what we anticipate for the latter half of the year. When we reviewed that guidance figure, our sense was that raising it was the right call. Yet on a dollar-for-dollar basis we chose to stay cautious, simply because certain unpredictable elements remain in the broader economy, and we wanted to account for those carefully. So in reviewing the guidance, our aim was to be fully at ease with the figure we released, anticipating continued growth in the back half, though possibly not precisely dollar-for-dollar in the way the first half delivered.

Andrew Kligerman

analyst
#15

I'm quite fond of the new KPIs. When you look at policies held, they dropped from 753 to 600 on a sequential basis; and naturally, that resulted from the annualized turnover ratio hitting 2.3x, which is significantly higher than the 1.5 to 2x typical level; so what I'm wondering is, at what point would you want that average turnover to stay within that 1.5 to 2x band? And where would you prefer to see the average policy count, or the number of policies held, remain on a fairly steady footing?

Jay Jackson

executive
#16

Absolutely. I appreciate that question, Andrew. And indeed, we provided that range to offer some direction regarding the 1.5 to 2. I believe that's a reasonable band. It might shift from quarter to quarter simply based on what investor demand looks like during that window and/or how our acquisitions have gone. To illustrate, should we originate more than usual in a given quarter, there could be a lag into the following quarter before those policy sales show up. So you might notice some variability in how many policies are held, though that reflects your turnover ratio for whichever quarter. That's precisely why we felt quite at ease with that 1.5 to 2. We believe it fully aligns with our position in Q2. Demand was elevated in Q2, and we managed to take advantage of it. Looking ahead as a pattern, we're seeing comparable demand with confidence and — it should develop in Q3 and possibly across the remainder of the year; however, we won't truly find out until we approach the quarter's close. Still, we feel very strongly positioned at present given how much capital we — sorry, cash and cash equivalents sitting on our balance sheet that we can deploy during these opportunistic moments. So I'm not sure there's a specific figure I could give you regarding policy count, since one quarter might involve purchasing smaller policies while another involves purchasing larger ones. Consequently, I'm not sure I'd pay as close attention to policy count as I would to the 1.5 to 2.

Andrew Kligerman

analyst
#17

That's quite logical. And regarding the impressive 26% increase you reported, I simply want to confirm I've got it right — is that just the price paid, meaning the denominator, while the numerator is what you got back? It isn't an annualized figure, so.

Jay Jackson

executive
#18

Right, that's the case. Yes, that's what took place during Q2. We therefore did better than our initial performance, which our past trade spreads had pointed to at nearer 22%; and should you check the KPIs in the updated deck, you will in fact see how we monitor that on your behalf, where you now examine that historical trade spread each quarter.

Andrew Kligerman

analyst
#19

That's quite impressive. Then, finally, regarding the G&A expenses sitting at $18.9 million — what's your outlook on that moving ahead? Will it move in line with revenue? Or do you anticipate holding it fairly flat? What's your perspective on G&A going forward?

Bill McCauley

executive
#20

It's going to increase alongside revenue, though not by an equivalent percentage. I'd say a few items flow through that line, including more staff to back our growth. Also, we've seen somewhat higher legal costs across the past couple of months; however, in terms of normalization, we anticipate coming in below that $18 million figure each quarter.

Randy Binner

analyst
#21

I'd like to ask about the related party transactions breakout expressed as a share of revenue. That disclosure is useful. Is that calculated on — is it based on — I'm assuming it's based on Life Solution revenue or total revenue, those percentages?

Jay Jackson

executive
#22

Yes, regarding those percentages, they would be calculated on total revenue. However, if you truly break it down, almost all of our revenue currently sits in Life Solutions. I mean, there certainly is some within Asset Management and a few other areas. But we looked at all the revenue against it simply because, mainly, that has been a major driver of our revenue on a percentage basis.

Randy Binner

analyst
#23

Yes. Understood. And there's another split I'd like to dig into; regarding the policies that were sold to third parties, could you — I believe this will also appear in the Q, but could you share some detail on the breakdown of insurance partners compared with financial investors?

Jay Jackson

executive
#24

Certainly; and yes, it's somewhat harder to separate out since what's going on, Randy, is that we end up servicing many of those assets on their behalf. And separating those out is at times a confidentiality request from them. But I think in our deck, you're able to see that the growth in the number of policies we service is quite significant. And we're continuing to grow the relationships with our carrier partners and also our reinsurers. And we're developing what I consider to be truly interesting structures so that they can take part in a more meaningful way.

Randy Binner

analyst
#25

All right, and if I could, just one additional question regarding Asset Management. That operation is still fairly new, so perhaps our expectations were too cautious, yet the fees relative to AUM came in somewhat above what we had projected. Is that — does anything stand out — is this the appropriate level? We're looking at roughly 27 basis points on AUM. I'm just curious how reliable a gauge that is, or whether it might improve further going forward.

Jay Jackson

executive
#26

Yeah, I believe we will keep seeing gains as time goes on. There's considerable interest coming our way in the Asset Management portion of what we do, and we're steadily developing that area of our operations, I'd say, quite substantially. And clearly, nobody can foresee what lies ahead, but our confidence is high regarding our current position, where those figures stand today, and we're encouraged that plenty of upside remains.

Mike Grondahl

analyst
#27

Nice work. I want to build on what was asked regarding the second half of the year. Jay, was your point that revenue and adjusted net income would rise on a sequential basis? During 2Q, you had what you called Liberation Day arrive early, with plenty of swings and plenty of doubt. Part of me suspects you enjoyed pricing leverage on both sides — first while sourcing policies, then while selling them. If even a small portion of that goes away, it eats into margin. So please just walk us through how to think about the coming couple of quarters on a sequential basis.

Jay Jackson

executive
#28

Absolutely. One thing we can do is examine the past as well. Looking back, on a sequential basis, Q3 and Q4 have consistently come in stronger for us than the year's first half. And the danger we may be walking into is this: you're correct that Q2 was outstanding. So what does Q3 look like if we're sequentially above Q2? I'm reviewing the consensus figures, and since we're now speaking with each of our analysts, honestly I'd prefer that you not push consensus upward. That said, joking aside, the momentum we've described throughout Q2 is something we feel confident about, and it has carried forward. There are still investors, and there remains appetite for this asset, meeting the rise in origination. Consider even the growth in our marketing spend — it's up quarter-over-quarter, and not merely widening the message everywhere with Abacus, but our marketing spend, including on our origination, we're bringing on new national account relationships. So as this message gains more validation and, I'd contend, becomes more ordinary, that keeps enhancing our origination. And adding to origination is our servicing book, which is our asset management fees, correct? Every one of these elements is starting to accumulate and smooth out, Mike, some of that unevenness you may expect to occur. So I believe that once you begin to publish these steady results the way we keep doing, that provides investors, and certainly shareholders, far more reassurance about what lies ahead.

Patrick Davitt

analyst
#29

One quick question about that $142 million in flows — is it gross or net? If it's gross, what's the net figure? It looks a lot like the number from 1Q, so is this roughly the run rate for the business, or should we expect some lumpiness as we head into the second half?

Jay Jackson

executive
#30

Sure, thank you, Patrick. Yes, that figure was gross. As for net, keep in mind it isn't all that far off, correct? The reason being that these assets flow into longer-term strategies. Looking back, what stands out about the capital raise is worth examining perhaps on an annualized basis. The bulk of the capital in our — within Q1, I'd say, arrived toward the back end of Q1, roughly the final 2 weeks of March. Then things began to normalize somewhat over the summer, and there's a possibility they could pick up in the year's second half. But consider this: across the last 4 months, we've brought in somewhere around almost $240-plus million, give or take. I won't make a forecast and claim that, since capital raising obviously can shift. Still, based on what I can see and where we stand, we feel good that this is — that the capital raise is becoming fairly consistent, and hopefully demand keeps up as we move into Q3 and Q4. One more thing I'd add: as we bring in more products in the alt space, that figure ought to keep growing. Sorry, and one further point on that, Patrick — the ETFs are the only net piece, at $11 million. Everything else is gross, yes.

Jay Jackson

executive
#31

Great. I'd like to pause for a second and express my appreciation to everybody. We feel enormous gratitude toward each of our shareholders and investors who have devoted their time to keep growing their understanding and to keep getting to know our story at a finer level of detail; and we remain dedicated to telling that story across a far wider scope, since we're confident it will keep developing alongside our company's development. When you consider the position our business occupies, it may sit in the earlier phases of possibly becoming one of the next truly big private credit asset managers, and we're solidly along that road. It's also a fitting moment to examine Abacus, because when we project ahead across the coming 1 year, 2 years, 3 years, 4 years, 5 years, we are unquestionably hitting and surpassing the targets we established for ourselves, and we will keep doing so; so I'm deeply thankful for all the backing you've given. I appreciate your joining this call. And should you ever want to get in touch with us or talk with us, we're absolutely here for you. Many thanks.

Operator

operator
#32

That wraps up our call. We appreciate everyone joining us for today's presentation. At this point, feel free to hang up your phones.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Abacus Global Management, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Abacus Global Management, Inc. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Abacus Global Management, Inc. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.